260 related articles for article (PubMed ID: 16040393)
1. Modulation of GvHD by suicide-gene transduced donor T lymphocytes: clinical applications in mismatched transplantation.
Ciceri F; Bonini C; Gallo-Stampino C; Bordignon C
Cytotherapy; 2005; 7(2):144-9. PubMed ID: 16040393
[TBL] [Abstract][Full Text] [Related]
2. Ganciclovir-mediated elimination of HSV-Tk+ T cells and cure of graft-vs-host disease in an allogeneic bone marrow transplantation model in the rat.
Weijtens M; van Spronsen A; Hagenbeek A; de Weger R; Martens A
Exp Hematol; 2004 Oct; 32(10):962-9. PubMed ID: 15504552
[TBL] [Abstract][Full Text] [Related]
3. Selective elimination of alloreactive donor T cells attenuates graft-versus-host disease and enhances T-cell reconstitution.
Gendelman M; Yassai M; Tivol E; Krueger A; Gorski J; Drobyski WR
Biol Blood Marrow Transplant; 2003 Dec; 9(12):742-52. PubMed ID: 14677113
[TBL] [Abstract][Full Text] [Related]
4. Suicide-gene-Transduced donor T-cells for controlled graft-versus-host disease and graft-versus-tumor.
Ciceri F; Bordignon C
Int J Hematol; 2002 Nov; 76(4):305-9. PubMed ID: 12463592
[TBL] [Abstract][Full Text] [Related]
5. Effect of combined cytostatic cyclosporin A and cytolytic suicide gene therapy on the prevention of experimental graft-versus-host disease.
Maury S; Litvinova E; Boyer O; Benard L; Bruel S; Klatzmann D; Cohen JL
Gene Ther; 2002 Feb; 9(3):201-7. PubMed ID: 11859423
[TBL] [Abstract][Full Text] [Related]
6. Hematopoietic stem cell graft manipulation as a mechanism of immunotherapy.
Talmadge JE
Int Immunopharmacol; 2003 Aug; 3(8):1121-43. PubMed ID: 12860168
[TBL] [Abstract][Full Text] [Related]
7. Herpes simplex thymidine kinase (HStk) transgenic donor lymphocytes.
Burt RK; Drobyski WR; Traynor AE; Link CJ
Bone Marrow Transplant; 1999 Nov; 24(10):1043-51. PubMed ID: 10578153
[TBL] [Abstract][Full Text] [Related]
8. Production and culture of HSVtk transduced suicidal lymphocytes induces variable changes in the lymphocyte subset composition.
Marini FC; Kornblau SM
Bone Marrow Transplant; 1999 May; 23(9):907-15. PubMed ID: 10338046
[TBL] [Abstract][Full Text] [Related]
9. Kinetics of cell death in T lymphocytes genetically modified with two novel suicide fusion genes.
Junker K; Koehl U; Zimmerman S; Stein S; Schwabe D; Klingebiel T; Grez M
Gene Ther; 2003 Jul; 10(14):1189-97. PubMed ID: 12833128
[TBL] [Abstract][Full Text] [Related]
10. Preemptive control of graft-versus-host disease in a murine allogeneic transplant model using retrovirally transduced murine suicidal lymphocytes.
Kornblau SM; Stiouf I; Snell V; Przepiorka D; Stephens LC; Champlin R; Marini FC
Cancer Res; 2001 Apr; 61(8):3355-60. PubMed ID: 11309292
[TBL] [Abstract][Full Text] [Related]
11. Selective removal of alloreactive cells from haematopoietic stem cell grafts: graft engineering for GVHD prophylaxis.
Koh MB; Prentice HG; Lowdell MW
Bone Marrow Transplant; 1999 May; 23(10):1071-9. PubMed ID: 10373075
[TBL] [Abstract][Full Text] [Related]
12. Megadose transplantation of purified peripheral blood CD34(+) progenitor cells from HLA-mismatched parental donors in children.
Handgretinger R; Klingebiel T; Lang P; Schumm M; Neu S; Geiselhart A; Bader P; Schlegel PG; Greil J; Stachel D; Herzog RJ; Niethammer D
Bone Marrow Transplant; 2001 Apr; 27(8):777-83. PubMed ID: 11477433
[TBL] [Abstract][Full Text] [Related]
13. Clinical-scale selective depletion of alloreactive T cells using an anti-CD25 immunotoxin.
Michálek J; Collins RH; Vitetta ES
Neoplasma; 2003; 50(4):296-9. PubMed ID: 12937844
[TBL] [Abstract][Full Text] [Related]
14. Facilitating T-cell immune reconstitution after haploidentical transplantation in adults.
Waller EK; Giver CR; Rosenthal H; Somani J; Langston AA; Lonial S; Roback JD; Li JM; Hossain MS; Redei I
Blood Cells Mol Dis; 2004; 33(3):233-7. PubMed ID: 15528137
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of graft-versus-host disease. Use of a T cell-controlled suicide gene.
Helene M; Lake-Bullock V; Bryson JS; Jennings CD; Kaplan AM
J Immunol; 1997 Jun; 158(11):5079-82. PubMed ID: 9164920
[TBL] [Abstract][Full Text] [Related]
16. Retrovirus mediated gene transduction of human T-cell subsets.
Hedfors IA; Beckstrøm KJ; Benati C; Bonini C; Brinchmann JE
Cancer Immunol Immunother; 2005 Aug; 54(8):759-68. PubMed ID: 15655695
[TBL] [Abstract][Full Text] [Related]
17. [Alloreactive donor lymphocytes (DLI) after allogeneic hematopoietic stem cell transplantation (HSCT): study of toxicity and efficacy].
Michallet AS; Nicolini F; Michallet M
Bull Cancer; 2003; 90(8-9):758-62. PubMed ID: 14609766
[TBL] [Abstract][Full Text] [Related]
18. Severe acute graft-versus-host disease after T-cell depleted allogeneic stem cell graft from a second donor caused by persisting T-cells from the first donor.
Wiesmann A; Bader P; Bamberg M; Faul C; Kanz L; Einsele H
Bone Marrow Transplant; 2003 Sep; 32(5):511-3. PubMed ID: 12942098
[TBL] [Abstract][Full Text] [Related]
19. Use of rituximab and irradiated donor-derived lymphocytes to control Epstein-Barr virus-associated lymphoproliferation in patients undergoing related haplo-identical stem cell transplantation.
McGuirk JP; Seropian S; Howe G; Smith B; Stoddart L; Cooper DL
Bone Marrow Transplant; 1999 Dec; 24(11):1253-8. PubMed ID: 10642818
[TBL] [Abstract][Full Text] [Related]
20. Cell therapy: achievements and perspectives.
Bordignon C; Carlo-Stella C; Colombo MP; De Vincentiis A; Lanata L; Lemoli RM; Locatelli F; Olivieri A; Rondelli D; Zanon P; Tura S
Haematologica; 1999 Dec; 84(12):1110-49. PubMed ID: 10586214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
